29.03.2012 • News • bio-based succinic acid • JV • Reverdia

Reverdia-Joint Venture Launched

Reverdia, the joint venture between Royal DSM and Roquette Frères, has been formally approved by the relevant regulatory authorities.

Reverdia aims to build on its emerging leadership position for bio-based succinic acid through its proprietary production technology and by ensuring reliable supply to meet the evolving market demands. Reverdia combines DSM's expertise in Materials Sciences, and biotechnology together with Roquette's know-how in plant-based raw material processing.

Bio-based succinic acid is derived from non-fossil feedstock and produced with sustainable production technologies that minimize carbon footprint. It is a building block that can be used in the manufacture of polymers, resins and many other products. Key applications include footwear, packaging and paints.

The new facility, scheduled to be operational by the end of Q3 2012 will have a capacity of about 10 kt, and is located on the Roquette site in Cassano Spinola, Italy. The proximity to the port of Genoa ensures efficient global logistics.

Company

Reverdia

Urmonderbaan 20H
6167 RD Geleen

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.